Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Epalrestat on Peripheral Neuropathy and Central Nervous System in Diabetic Patient

NCT05184049 is registered in ClinicalTrials.gov with Xiangya Hospital of Central South University as lead sponsor.

NCT NCT05184049
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05184049 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Epalrestat on Peripheral Neuropathy and Central Nervous System in Diabetic Patient
Lead sponsor
Xiangya Hospital of Central South University
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2022
Completion date
October 31, 2023
Enrollment
72 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes